First-in-human trial of TEAD inhibitor BPI-460372 shows early signals and safety limits
A first-in-human phase Ia trial reports that the covalent TEAD palmitoylation inhibitor BPI-460372 showed preliminary antitumor activity in advanced solid ...
A first-in-human phase Ia trial reports that the covalent TEAD palmitoylation inhibitor BPI-460372 showed preliminary antitumor activity in advanced solid ...
A review in Acta Neuropathologica Communications describes how aberrant liquid-liquid phase separation may drive glioblastoma progression and therapy resistance, and ...
A new review proposes a two-layer signaling network organizing female germline stem cell fate as a testable framework for staged ...
A single-nucleus atlas of human visceral fat identifies THBS1-expressing stem cells and adipocytes as drivers of fibro-inflammatory remodeling in obesity ...
A new review in Biogerontology argues that the Hippo–YAP/TAZ signalling pathway acts as a central hub linking brain ageing, neurodegeneration, ...
A new review in Reproductive Sciences proposes that tissue stiffness and mechanotransduction pathways may help explain the heterogeneity and progression ...
A new review in Molecular Cancer proposes that mechanical forces within tumors can reprogram RNA modifications, offering a fresh framework ...
New research shows that the endothelial protein Epac1 drives melanoma growth and angiogenesis by coordinating VEGFR2 signalling, RhoA-dependent cytoskeletal dynamics, ...
New research shows that the transcription factor SOX9 primes Hippo–YAP/TAZ pathway rewiring during a narrow early window of stemness acquisition ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine